US Patent 11007275 Cryptophycin antibody conjugates for the treatment of cancer

Patent 11007275 was granted and assigned to Sanofi on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Sanofi

Current Assignee

Sanofi

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11007275

Patent Inventor Names

Hervé Bouchard0

Marie-Priscille Brun0

Philippe Hubert0

Date of Patent

May 18, 2021

Patent Application Number

16673367

Date Filed

November 4, 2019

Patent Citations Received

‌

US Patent 11998611 Cryptophycin antibody conjugates for the treatment of cancer

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

The present disclosure relates to compounds of formula (V):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11007275 Cryptophycin antibody conjugates for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API